NINA VOIGT: Open Payments
NPI 1932822962 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$782 in 9 payments from 7 companies in 2025. Trend: 2023 $2,450 · 2024 $2,050 · 2025 $782
Food & beverage: $782
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $249 |
| Janssen Pharmaceuticals, Inc | 1 | $129 |
| Otsuka America Pharmaceutical, Inc. | 1 | $124 |
| Axsome Therapeutics, Inc. | 1 | $119 |
| Vanda Pharmaceuticals Inc. | 1 | $106 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Exact Sciences Corporation | 1 | $20 |
Products named: INGREZZA, SPRAVATO, REXULTI, Auvelity, FANAPT, CAPLYTA, Cologuard Collection Kit.
Industry payments across IN — which companies pay providers there.
